On-Demand Parenting Webinars

Free Webinar Replay: Marijuana and the ADHD Brain: How to Identify and Treat Cannabis Use Disorder in Teens and Young Adults

In this hour-long webinar-on-demand, learn how to identify and treat cannabis use disorder in teens and young adults, with Roberto Olivardia, Ph.D.

Individuals with ADHD carry a higher risk for substance use problems. Cannabis is one of the most widely abused substances among people with ADHD; studies show that those diagnosed with the condition are more likely to develop a Cannabis Use Disorder. One study found that 34% to 46% of those seeking treatment for cannabis dependence had an ADHD diagnosis.

Many parents and adults assume that cannabis is safe — even medicinal — for ADHD. These assumptions have been bolstered by the legalization of cannabis in more and more states. However, this is far from the truth, especially in young people. Cannabis carries lifelong psychological and physical consequences to the developing brain and body, and people with ADHD are especially vulnerable to its effects. Though marijuana use is a hotly debated topic, this webinar focuses on strong scientific studies and clinical examples to drive home the cannabis-ADHD connection.

In this webinar, you will learn:

  • The prevalence of cannabis use in ADHD groups
  • Why cannabis can appeal to an ADHD brain
  • Effects of cannabis on the developing ADHD brain
  • Distinguishing between proper pharmacology and self-medication
  • Treatment recommendations for people affected by ADHD and Cannabis Use Disorder

Webinar replays include:

  • Slides accompanying the webinar
  • Related resources from ADDitude
  • Free newsletter updates about ADHD
  • An opportunity to receive a certificate of attendance

Certificate of Attendance
Attendees who successfully complete a survey after watching this webinar will be eligible to receive a one hour certificate of attendance. ADDitude does not offer CEU credits.

This ADHD Experts webinar was first broadcast live on February 26, 2020.


Meet the Expert Speaker:

Dr. Roberto Olivardia is a clinical psychologist and lecturer in psychology in the Department of Psychiatry at Harvard Medical School. He maintains a private psychotherapy practice in Lexington, Massachusetts, where he specializes in the treatment of Attention Deficit Hyperactivity Disorder (ADHD), Obsessive-Compulsive Disorder (OCD), Body Dysmorphic Disorder (BDD) and Eating Disorders. He has spoken on numerous webinars and presents at many talks and conferences around the country. He currently serves on the Scientific Advisory Board for ADDitude, as well as the Professional Advisory Boards for Children and Adults with ADHD (CHADD), the Attention Deficit Disorder Association (ADDA) and the National Association for Males with Eating Disorders. He is also a member of the ADDitude ADHD Medical Review Panel and a paid consultant for Understood.org.

 

3 Related Links

  1. cannabis surely a lot better for you than taking amphetamine based medication for ADHD. Sure, smoking carries an obvious health risk, but in children ADHD medication stunts your growth.

  2. I take Adderall which works for me. It’s a very low dose and I’m not worried about addiction. It does not make me hyper, it makes me normal, able to focus, and clears my mind. I take it with breakfast and it tapers off at the end of the day. I only wish that I had taken it earlier especially while in college.

  3. Firstly I am opposed to using any recreational drugs, including alcohol, prior to the age of 18. Continuing brain development or not I consider it excessive to restrict it to under 25.

    However having done some searching I am getting the feeling that there was a lot of cherry picking involved in the results presented in this webinar. Madeline H. Meier’s study for instance was subsequently criticised due to problems with its methods. And why mention that paper, but fail to mention other, later, papers that found no decline in IQ? My overall impression is that this webinar, in spite of the presenters protestations to the contrary, is aimed at creating fear, uncertainty and doubt. He repeatedly fails to give any information on what levels of use are involved in the outcomes he claims are linked to cannabis use. Are all these scary outcomes linked to moderate use, e.g. once a day or a few times a week, or only to using it all day every day? What are the dose sizes?

    And really haven’t we put the gateway drug myth to bed already?

    I’m also inclined to generally mistrust claims about increased potency. There may indeed be some very strong strains today, but I’d want to see evidence that they were comparing like for like, i.e. the strongest then versus the strongest now. I’d also want to know the prevalence of those stronger varieties and how users are consuming them. In my experience users prefer stronger varieties because it allows them to achieve the same result from a smaller quantity. They don’t simply continue to use the same quantity regardless of potency.

Leave a Reply